Fas-associated death domain protein is a Fas-mediated apoptosis modulator in synoviocytes

Rheumatology

Volumn 39, Issue 5, 2000, Pages 471-480

  Okamoto, K ^a   Kobayashi, T ^a   Kobata, T ^a,b   Hasunuma, T ^a   Kato, T ^a   Sumida, T ^a   Nishioka, K ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Caspase; FADD; Fas; Rheumatoid arthritis

Indexed keywords

CASPASE 3; CASPASE 8; ENZYME INHIBITOR; FAS ANTIGEN; INTERLEUKIN 1BETA CONVERTING ENZYME; MONOCLONAL ANTIBODY; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIOCYTE;

EID: 0034113233     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/39.5.471     Document Type: Article

References (45)

1. Harris EDJ. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990;322:1277 89.
2. Zvaiflcr NJ. Rheumatoid arthritis- The multiple pathways to chronic rheumatoid synovitis. Lab Invest 1995;73:307-10.
3. Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K et al. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 1995;38:485 91.
4. Firestein GS, Yeo M, Zvaifler NJ. Apoptosis in rheumatoid arthritis synovium. J Clin Invest 1995;96:1631 8.
5. Hoa TTM, Hasunuma T, Aono H et al. Novel mechanisms of selective apoptosis in synovial T cells of patients with rheumatoid arthritis. J Rheumatol 1996;23:1332 7.
6. Fujisawa K, Asahara H, Okamoto K et al. Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice. J Clin Invest 1996;98:271 8.
7. Okamoto K, Asahara H, Kobayashi T et al. Induction of apoptosis in the rheumatoid synovium by Fas ligand gene transfer. Gene Ther 1998;5:331 8.
8. Krammer PH, Dhein J, Walczak H et al. The role of APO-1-mediated apoptosis in the immune system. Immunol Rev 1994;142:175 91.
9. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D. A novel protein that interacts with the death domain of FAS/APO-1 contains a sequence motif related to the death domain. J Biol Chem 1995;270:7795 8.
10. Chinnaiyan AM. O'Rourke KO, Tewari M, Dixit VM. FADD, a novel death-domain containing protein interacts with the death domain of Fas and initiates apoptosis. Cell 1995;81:505 12.
11. Kischkel FC, Hellbardt S, Behrmann I et al. Cytotoxicity-dependent APO-1 (Fas/CD95) associated proteins form a death-inducing signaling complex ( DISC ) with the receptor. EMBO J 1995;14:5579 88.
12. Sato T, Irie S, Kitada S, Reed JC. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 1995;268:411 5.
13. Yanagisawa J, Takahashi M, Kanki H et al. The molecular interaction of Fas and FAP-1. J Biol Chem 1997; 272:8539-45.
14. Stanger BZ, Leder P, Lee TH, Kim E, Seed B. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 1995;81:513 23.
15. Irmler M, Thome M, Hahne M et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997;388:190 5.
16. Alnemri ES, Livingston DJ, Nicholson DW et al. Human ICE/CED-3 protease nomenclature. Cell 1996;87:171.
17. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. Involvement of MACH, a novel MOLT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell 1996;85:803 15.
18. Muzio M, Chinnaiyan AM, Kischkel FC et al. FLICE, a novel FADD-homologous ICE/CED-3-like prolease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996;85:817 27.
19. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
20. Hasunuma T, Nakajima T, Aono H et al. Establishment and characterization of synovial cell clones with integrated human T-cell leukemia virus type-1. Clin Immunol Immunopathol 1994;72:90 7.
21. Asahara H, Hasunuma T, Kobata T et al. Expression of Fas antigen and Fas ligand in the rheumatoid synovial tissue. Clin Immunol Immunopathol 1996;81:27 34.
22. Kobayashi T, Okamoto K. Kobata T, Hasunuma T, Sumida T, Nishioka K. Tumor necrosis factor a regulation of the Fas-mediated apoptosis signaling pathway in synovial cells. Arthritis Rheum 1999;42:519 26.
23. Sekine C, Yagita H, Kobata T, Hasunuma T, Nishioka K. Okumura K. Fas-mediated stimulation induces IL-8 secretion by rheumatoid arthritis synoviocytes independently of CPP32-mediated apoptosis. Biochem Biophys Res Commun 1996;228:14 20.
24. Nicholson DW, Ali A, Thornberry NA et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995;376:37-43.
25. Satoh MS, Lindahl T. Role of poly(ADP-ribose) formation in DNA repair. Nature 1992;356:356 8.
26. 2+-dependent endonuclease activity by nicotinamide adenine dinucleotide and poly(adenosine diphosphate ribose) synthetase. Biochem Biophys Res Commun 1974;59:658 65.
27. 2+-dependent endonuclease. Proc Natl Acad Sci USA 1975; 72:289 93.
28. 2+-dependent endonuclease of bull seminal plasma induced by ADP-ribosylation. J Biol Chem 1984;259:6579 85.
29. Enari M, Taranian RV, Wong WW, Nagata S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 1996;380:723 6.
30. Li P, Allen H, Banerjee S et al. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 1995; 80:401 11.
31. Kuida K, Zheng TS. Na S-Q et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996;384:368 72.
32. Peter ME, Kischkel FC, Scheuerpflug CG, Medema JP, Debatin KM, Krammer PH. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/ Caspase-8) to the CD95 death-inducing signaling complex. Eur J Immunol 1997;27:1207 12.
33. Wajant H, Johannes F-J, Haas E et al. Dominant-negative FADD inhibits TNFR60-, Fas/Apol- and TRAIL-R/Apo2-mediated cell death but not gene induction. Curr Biol 1998;8:113 6.
34. Okamoto K, Fujisawa K, Hasunuma T, Kobata T, Sumida T, Nishioka K. Selective activation of the JNK/AP-1 pathway in Fas-mediated apoptosis of rheumatoid arthritis synoviocytes. Arthritis Rheum 1997;40: 919 26.
35. Wilson DJ, Fortner KA, Lynch DH et al. JNK, but not MAPK, activation is associated with Fas-mediated apoplosis in human T cells. Eur J Immunol 1996;26: 989 94.
36. Latinis KM, Koretzky GA. Fas ligation induces apoptosis and Jun kinase activation independently of CD45 and Lck in human Tcells. Blood 1996;87:871-5.
37. Goillot E, Raingeaud J, Ranger A et al. Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc Natl Acad Sci USA 1997;94:3302-7.
38. Juo P, Kuo CJ, Reynolds SE et al. Fas activation of the p38 mitogen-activated protein kinase signaling pathway requires ICE/CED-3 family proteases. Mol Cell Biol 1997;17:24-35.
39. Yang X, Far RK, Chag HY, Baltimore D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 1997;89:1067-76.
40. Lenczowski JM, Dominguez L, Eder AM, King LB. Zacharchuk CM, Ashwell JD. Lack of a role for jun kinase and AP-1 in Fas-induced apoptosis. Mol Cell Biol 1997;17:170-81.
41. Hengartner MO, Horvitz HR. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 1994;76:665-76.
42. Armstrong RC, Aja T, Xiang J et al. Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors. J Biol Chem 1996;271:16850-5.
43. Kobayashi T, Okamoto K, Kobata T et al. Differential regulation of Fas-mediated apoptosis of rheumatoid synoviocytes by tumor necrosis factor α and basic fibroblast growth factor is associated with the expression of apoptosis-related molecules. Arthritis Rheum 2000;43:in press.
44. Firestein GS, Nguyen K, Aupperle KR, Yeo M, Boyle DL, Zvaifler NJ. Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am J Pathol 1996;149:2143-51.
45. Aupperle KR, Boyle DL, Hendrix M et al. Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene. Am J Pathol 1998;152:1091-8.